CompanyGraph
Shanghai Aohua Photoelectricity Endoscope Co., Ltd.
688212 · SSE · China
aohua.comFinancials as of FY2025
At a glance
- Depends onMidstream position: 6 outgoing, 8 incoming connections
- FinancialsLow earnings quality
- Interpretations1 currently firing — 1
Sign in to view price data.
Sign inThe reported statements, read against the company's own industry.
Financials view
Market Capitalization
3.89BCNY580.73M · vs all stocks (USD)
Revenue (TTM)
793.05MCNY118.38M · vs all stocks (USD)
Profit Margin
-4.21%vs Medical Devices peers
Beta
-0.3460xvs all stocks
52-Week Change
-37.87%vs all stocks
Market Capitalization
3.89BCNY580.73M · vs all stocks (USD)
Enterprise Value
3.79BCNY565.00M · vs all stocks (USD)
Forward P/E
44.88xvs Medical Devices peers
Price to Sales (TTM)
4.69xvs Medical Devices peers
Price to Book (MRQ)
3.04xvs Medical Devices peers
Enterprise to Revenue
4.77xvs Medical Devices peers
Gross Margin
56.34%vs Medical Devices peers
Profit Margin
-4.21%vs Medical Devices peers
Operating Margin
-50.41%vs Medical Devices peers
Return on Assets (TTM)
-1.93%vs Medical Devices peers
Return on Equity (TTM)
-2.64%vs Medical Devices peers
Revenue (TTM)
793.05MCNY118.38M · vs all stocks (USD)
Revenue per Share (TTM)
6.28CNYUpdated Sep 22, 2026Quarterly Revenue Growth
4.00%vs Medical Devices peers
Gross Profit (TTM)
493.33MCNY73.64M · vs all stocks (USD)
EBITDA (TTM)
118.11MCNY17.63M · vs all stocks (USD)
Net Income (TTM)
-33.40MCNY-4.99M · vs all stocks (USD)
Quarterly Earnings Growth (YoY)
3.96%vs Medical Devices peers
Operating Cash Flow (TTM)
-2.47MCNY-367.98K · vs all stocks (USD)
Levered Free Cash Flow (TTM)
-24.72MCNY-3.69M · vs all stocks (USD)
Payout Ratio
0.00%vs Medical Devices peers
Minority Interest (Equity)
13.56MCNYFY2025 · Dec 31, 2025Revenue
773.87MCNYFY2025 · Dec 31, 2025Cost of Goods Sold
269.00MCNYFY2025 · Dec 31, 2025Gross Profit
504.86MCNYFY2025 · Dec 31, 2025Operating Income
42.04MCNY6.27M · vs all stocks (USD)
Pre-tax Income
117.12KCNYFY2025 · Dec 31, 2025Income Tax Expense
-10.47MCNYFY2025 · Dec 31, 2025Net Income
10.59MCNYFY2025 · Dec 31, 2025EBIT
7.04MCNYFY2025 · Dec 31, 2025EBITDA (Income Statement)
118.11MCNYFY2025 · Dec 31, 2025Research & Development
147.01MCNYFY2025 · Dec 31, 2025Selling, General & Administrative
113.88MCNYFY2025 · Dec 31, 2025Other Operating Expenses
19.02MCNYFY2025 · Dec 31, 2025Non-operating Interest Income
3.03MCNYFY2025 · Dec 31, 2025Non-operating Interest Expense
6.92MCNYFY2025 · Dec 31, 2025EPS (Basic)
0.0900CNYFY2025 · Dec 31, 2025EPS (Diluted)
0.0900CNYFY2025 · Dec 31, 2025Basic Shares Outstanding
127.24MSharesFY2025 · Dec 31, 2025Diluted Shares Outstanding
127.24MSharesFY2025 · Dec 31, 2025Net Income from Continuing Operations
10.59MCNYFY2025 · Dec 31, 2025Minority Interests (P&L)
865.75KCNYFY2025 · Dec 31, 2025Preferred Stock Dividends
0.00CNYFY2025 · Dec 31, 2025Operating Cash Flow
-115.00MCNYFY2025 · Dec 31, 2025Free Cash Flow
-245.12MCNYFY2025 · Dec 31, 2025Cash & Cash Equivalents (End of Period)
338.58MCNYFY2025 · Dec 31, 2025Starting Profit (CF Statement)
10.59MCNYFY2025 · Dec 31, 2025Other Non-cash Items
17.82MCNYFY2025 · Dec 31, 2025Change in Accounts Receivable (CF)
-116.03MCNYFY2025 · Dec 31, 2025Change in Other Assets/Liabilities
-27.37MCNYFY2025 · Dec 31, 2025Capital Expenditures
-130.13MCNYFY2025 · Dec 31, 2025Purchase of Investments
-846.00MCNYFY2025 · Dec 31, 2025Sale of Investments
924.29MCNYFY2025 · Dec 31, 2025Net Investing Cash Flow
-51.84MCNYFY2025 · Dec 31, 2025Long-term Debt Issuance
405.18MCNYFY2025 · Dec 31, 2025Long-term Debt Payments
-179.45MCNYFY2025 · Dec 31, 2025Common Dividends Paid
-16.58MCNYFY2025 · Dec 31, 2025Other Financing Charges
-52.07MCNYFY2025 · Dec 31, 2025Net Financing Cash Flow
157.08MCNYFY2025 · Dec 31, 2025Shares Outstanding
134.67MSharesUpdated Sep 22, 2026Float Shares
87.57MSharesUpdated Sep 22, 2026% Held by Insiders
32.85%vs all stocks
% Held by Institutions
23.67%vs all stocks
Total Cash (MRQ)
355.19MCNY53.02M · vs all stocks (USD)
Total Cash per Share (MRQ)
2.64CNYUpdated Sep 22, 2026Total Debt (MRQ)
409.04MCNY61.06M · vs all stocks (USD)
Total Debt to Equity (MRQ)
0.3306xvs Medical Devices peers
Current Ratio (MRQ)
1.75xvs Medical Devices peers
Book Value per Share (MRQ)
9.08CNYUpdated Sep 22, 2026Total Assets
2.00BCNY298.06M · vs all stocks (USD)
Total Current Assets
1.09BCNYFY2025 · Dec 31, 2025Total Liabilities
670.42MCNYFY2025 · Dec 31, 2025Total Non-current Assets
902.23MCNYFY2025 · Dec 31, 2025Total Non-current Liabilities
120.74MCNYFY2025 · Dec 31, 2025Total Current Liabilities
549.68MCNYFY2025 · Dec 31, 2025Cash
339.57MCNYFY2025 · Dec 31, 2025Cash Equivalents
2.30MCNYFY2025 · Dec 31, 2025Cash & Cash Equivalents
341.86MCNYFY2025 · Dec 31, 2025Other Short-term Investments
50.01MCNYFY2025 · Dec 31, 2025Accounts Receivable
431.62MCNYFY2025 · Dec 31, 2025Inventory
229.37MCNYFY2025 · Dec 31, 2025Accounts Payable
164.83MCNYFY2025 · Dec 31, 2025Short-term Debt
300.64MCNYFY2025 · Dec 31, 2025Other Current Liabilities
400.93KCNYFY2025 · Dec 31, 2025Long-term Debt
39.61MCNYFY2025 · Dec 31, 2025Other Non-current Liabilities
42.40MCNYFY2025 · Dec 31, 2025Common Stock (Book)
134.67MCNYFY2025 · Dec 31, 2025Retained Earnings
141.11MCNYFY2025 · Dec 31, 2025Total Shareholders' Equity
1.33BCNY197.99M · vs all stocks (USD)
Treasury Stock
40.02MCNYFY2025 · Dec 31, 202552-Week Low
24.89CNYUpdated Sep 22, 202652-Week High
53.01CNYUpdated Sep 22, 202652-Week Change
-37.87%vs all stocks
Beta
-0.3460xvs all stocks
50-Day MA
28.41CNYUpdated Sep 22, 2026200-Day MA
35.80CNYUpdated Sep 22, 2026Avg 10-Day Volume
1.41MSharesUpdated Sep 22, 2026Avg 30-Day Volume
3.08MSharesUpdated Sep 22, 2026Diluted EPS (TTM)
-0.2500CNYUpdated Sep 22, 20261 interpretation currently present — each is a set of fired observations whose alignment reads as one structural pattern. Click an observation to see the numbers behind it.
Screen for these patternsHow does this company use capital?
Minimal Tax and Interest Drag
Almost nothing is lost between its operating profit and its net income.
Reads
An interpretation is present only while every observation it reads stays fired (score ≥ 70). It describes what the aligned readings show — never a verdict, never a prediction.
Shared structure with peers — never a ranking.
Relationships view
Structural observations derived from financial data, industry benchmarks, and supply chain position.
Structural Tensions
High gross margins eroded by operating costsNotable
Gross Margin: 0.56Profit Margin: -0.04
Financial Health
Low earnings qualitySignificant
Earnings Quality Score: -4.36
Altman Z-Score 4.31: safe zoneNotable
Altman Z-Score: 4.31
Supply Chain
Midstream position: 6 outgoing, 8 incoming connectionsNotable
Outgoing: 6.00Incoming: 8.00
High connectivity hub: 14 industry connectionsNotable
Total Connections: 14.00
Companies that share the same coordination system — how they create, deliver, or capture value.
MapLight Therapeutics, Inc.
Tier 1ProductionApproval-Gated PipelineRule
Zhejiang Yatai Pharmaceutical Co., Ltd.
Tier 1ProductionApproval-Gated PipelineRuleFlow
Qurient Co., Ltd.
Tier 1ProductionApproval-Gated PipelineRuleSenseMaking
Gansu Longshenrongfa Pharmaceutical Co., Ltd.
Tier 1ProductionApproval-Gated PipelineRule
Hainan Shuangcheng Pharmaceuticals Co. Ltd.
Tier 1ProductionApproval-Gated PipelineRule
Zeria Pharmaceutical Co., Ltd.
Tier 1ProductionApproval-Gated PipelineRule
Newland Pharmaceuticals Co., Ltd.
Tier 1ProductionApproval-Gated PipelineRule
Zhejiang Sunflower Great Health Co., Ltd.
Tier 1ProductionApproval-Gated PipelineRuleFlow
ChemoCentryx Inc
Tier 1ProductionApproval-Gated PipelineRule
Jiangsu Sihuan Bioengineering Co., Ltd.
Tier 1ProductionApproval-Gated PipelineRuleFlow
Companies that share active interpretations — structural patterns currently present in both stocks.
Anbio Biotechnology Limited
1 interpretationMinimal Tax and Interest Drag
Hafnia Limited
1 interpretationMinimal Tax and Interest Drag
Shenzhen Inovance Technology Co., Ltd.
1 interpretationMinimal Tax and Interest Drag